Tim Singleton, MD

Dr. Singleton is board certified in anatomic and clinical pathology and has subspecialty boards in hematology (hematopathology). He trained at the University of Minnesota (medical school, residency, and hematopathology) and Stanford University (surgical pathology). He had prior instructor or faculty appointments at Stanford University; at the University of Michigan in Ann Arbor; at William Beaumont Hospital in Royal Oak, Michigan; and at the University of Minnesota. Early in his career, his clinical sign-out responsibilities included general surgical pathology and hematopathology, but over the years, he transitioned to hematopathology, including flow cytometry. Most recently, he was the medical director of the clinical flow cytometry laboratory at the University of Minnesota for 10 years. He has more than 40 peer-reviewed publications. He has proposed a classification for clonal large granular T lymphocytes (LGL) of alpha-beta T cells: T-cell clones of undetermined significance (TCUS), T-cell immunoclones (TIC), and LGL leukemias (American Journal of Clinical Pathology 2015;144[1]:137-44.)